Home
Resources
Diseases
Compendium
Training
Evaluation
The Tool
The Tutorial
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Type of publications
Guidelines (30)
NITAG documentation (1591)
Reports (55)
SAGE documentation (218)
Scientific publications (112)
Systematic reviews (SYSVAC) (2750)
Regions
Africa (267)
Americas (762)
Eastern Mediterranean (48)
Europe (704)
South-East Asia (78)
Western Pacific (196)
Diseases
Chikungunya (9)
Cholera (33)
COVID-19 (1481)
Cytomegalovirus (1)
Dengue (39)
Diphtheria (79)
Ebola (16)
Escherichia coli (ETEC) (2)
Haemophilus influenzae type B (66)
Hepatitis A (63)
Hepatitis B (153)
Hepatitis C (4)
Hepatitis E (5)
Herpes simplex (1)
Herpes zoster (66)
HIV / AIDS (10)
Human papillomavirus (HPV) (472)
Influenza (573)
Japanese encephalitis (34)
Lyme disease, Borreliosis (1)
Malaria (27)
Measles (128)
Meningococcal disease (145)
Mpox (55)
Mumps (46)
Pertussis (104)
Pneumococcal disease (266)
Poliomyelitis (84)
Q fever (1)
Rabies (28)
Rotavirus (115)
RSV (Respiratory syncytial virus) (47)
Rubella (64)
Salmonella (2)
Shigella (1)
Smallpox (16)
Streptococcus group B (6)
Tetanus (59)
Tick-borne encephalitis (12)
Tuberculosis (73)
Typhoid (23)
Varicella (69)
Yellow fever (42)
Zika (1)
Show more
4756 results found
2021
∙
CAVEI
CAVEI ordinary meeting December 29th 2021
2021
∙
CAVEI
CAVEI ordinary meeting November 24th 2021
2021
∙
CAVEI
CAVEI recommendation for the prioritization of COVID-19 vaccination in adolescents aged 12 to 17 years - 15 June 2021
2021
∙
CAVEI
CAVEI recommendation on the introduction of a booster dose to the COVID-19 Vaccination Plan - 29 July 2021
2021
∙
CAVEI
CAVEI recommendations for the use of the AstraZeneca COVID-19 vaccine - 5 June 2021
2021
∙
CAVEI
CAVEI's recommendation on the use of COVID-19 vaccines and other programmatic vaccines or vaccination campaigns
2021
∙
CAVEI
CAVEI's statement on the use of COVID-19 vaccines in pregnant and lactating women
2021
∙
Fleming-Dutra, K. E., ACIP
CDC plans for COVID-19 vaccine effectiveness evaluation post-authorization and post-licensure
2021
∙
Jessica MacNeil, ACIP
Clinical Considerations for Use of COVID-19 Vaccines
2021
∙
ATAGI
Clinical guidance on use of COVID-19 vaccine in Australia in 2021
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register